申请人:MALLINCKRODT INC.
公开号:US20030158127A1
公开(公告)日:2003-08-21
The present invention discloses novel sulfenate derivatives and their bioconjugates for phototherapy of tumors and other lesions. The sulfenates of the present invention are designed to absorb low-energy ultraviolet, visible, or near-infrared (NIR) region of the electromagnetic spectrum. The phototherapeutic effect is caused by direct interaction of free radicals, the reactive intermediate produced upon photofragmentation of the sulfenate moiety, with the tissue of interest.
本发明公开了用于肿瘤和其他病变光疗的新型亚磺酸盐衍生物及其生物结合剂。本发明的亚硫酸盐可吸收电磁波谱中的低能量紫外线、可见光或近红外(NIR)区域。光疗效果是由自由基(亚磺酸盐分子光碎裂时产生的活性中间体)与相关组织的直接相互作用引起的。